University of Tennessee/Erlanger Oncology and Hematology — Chattanooga, Tennessee

University of Tennessee/Erlanger Oncology and Hematology is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Tennessee/Erlanger Oncology and Hematology has participated in 1 clinical trials.

Therapeutic areas: Advanced Breast Cancer, Metastatic Breast Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee/Erlanger Oncology and Hematology?

University of Tennessee/Erlanger Oncology and Hematology has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee/Erlanger Oncology and Hematology conducted?

University of Tennessee/Erlanger Oncology and Hematology has 1 clinical trials on record. Their work covers Advanced Breast Cancer, Metastatic Breast Cancer.

Is University of Tennessee/Erlanger Oncology and Hematology accredited by Crixeo Health?

University of Tennessee/Erlanger Oncology and Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee/Erlanger Oncology and Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.